CTRI/2021/04/033007.

Study name	CTRI/2021/04/033007
Methods	Randomised, parallel‐group, placebo‐controlled trial method
Participants	Inclusion criteria: patients with size 7fr Triple lumen catheter duration of catheter placed up to 14 days Exclusion criteria: pregnancy allergic to heparin patient refusal coagulation disorders haemodialysis catheter
Interventions	UFH vs NS
Outcomes	Primary outcome: occlusion of CVC (time point: 14 days) Secondary outcome: patency (time point: checked daily for 14 days)
Starting date	26 April 2021 (date of first enrolment)
Contact information	Venkatraman Rajagopalan (drvenkat94@gmail.com)
Notes